Filter
358
Filtered Results: 358
Text search:
drogen
Featured
Recommendations
34
New Publications
75
Language
Document type
No document type
154
Studies & Reports
70
Guidelines
45
Brochures
30
Fact sheets
20
Manuals
12
Strategic & Response Plan
9
Training Material
6
Resource Platforms
5
Infographics
4
Dashboards/Maps
1
App
1
Online Courses
1
Countries / Regions
Germany
137
Eastern Europe
13
Global
11
Western and Central Europe
6
Russia
6
Congo, Democratic Republic of
4
Switzerland
3
Ukraine
3
Namibia
3
Senegal
2
Malawi
2
Africa
2
Asia
2
Venezuela
2
Indonesia
2
India
2
Tajikistan
1
Nepal
1
Kenya
1
Serbia
1
Benin
1
Togo
1
China
1
Rwanda
1
Syria
1
Nigeria
1
Burkina Faso
1
Peru
1
Austria
1
Mozambique
1
USA
1
Haiti
1
Saudi Arabia
1
Middle East and North Africa
1
South–East Asia Region
1
Paraguay
1
Belarus
1
South Africa
1
Brazil
1
Egypt
1
Yemen
1
Georgia
1
Ethiopia
1
Angola
1
Chad
1
South Sudan
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
45
Public Health
11
Women & Child Health
10
Clinical Guidelines
9
Key Resources
3
Capacity Building
1
Toolboxes
Refugee
150
Mental Health
78
NCDs
29
Global Health Education
22
COVID-19
14
Malaria
13
TB
12
Health Financing Toolbox
9
HIV
7
Planetary Health
6
Conflict
5
Ebola & Marburg
3
Social Ethics
3
Caregiver
3
Pharmacy
3
AMR
3
Disability
2
Rapid Response
1
Specific Hazards
1
The Federal Centre for Health Education (BZgA) emphasizes the critical role of drug prevention in enhancing public health in Germany. Annually, the country faces significant premature mortality due to substance use: at least 110,000 deaths from smoking, 40,000 from harmful alcohol consumption, and a...
The pamphlet "Oxycodone" provides an overview of the opioid drug class, explaining its uses, effects, and risks. It describes positive effects like euphoria and pain relief, alongside negative effects such as respiratory depression, confusion, and constipation. Withdrawal symptoms include anxiety, i...
The pamphlet "Methamphetamine" provides information about methamphetamine, an illegal stimulant with high abuse potential, though it has limited medical uses for conditions like ADHD and narcolepsy. It explains short-term effects such as appetite suppression, increased heart rate and blood pressure,...
Welcome to the Global Information System on Resources for the Prevention and Treatment of Substance Use Disorders. These pages present data collected from WHO Member States in broad categories: governance, policy and financing, service organization and delivery, human resources and national informat...
This guide helps pharmacists to understand their role in the hypertension program. From maintaining hypertensive drug stock, to drug dispensing, to recording and reporting, to awareness generation with patients.
Shown in blue is the estimated annual number of deaths attributed to drug use. Shown in red is theestimated annual number of deaths from drug use disorders. The difference between them is that theyrelate to indirect and direct causes of death, respectively.
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
Estimated annual number of deaths from drug use disorders, by type of drug.
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi...
Estimated annual number of deaths from drug use disorders per 100,000 people.
Trop. Med. Infect. Dis. 2022, 7, 152. https://doi.org/10.3390/tropicalmed7080152
Infection and Drug Resistance 2020:13 4047–4060
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...
Meeting report, Kampala, Uganda,
7–8 November 2023
Launch of the WHO Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019). Key findings
The Severe Malaria Observatory (SMO) is a global knowledge platform designed to enable professionals working on severe malaria, such as researchers, clinicians, public health experts, programme managers, policymakers and technical partners, to access, share and analyse reliable data on malaria compl...
The ACT Consortium was an international research collaboration dedicated to evaluating the effectiveness, safety and implementation of artemisinin-based combination therapies (ACTs) for treating malaria. Operating across multiple countries in Africa and Asia, the consortium conducted over 25 studies...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex F
The pamphlet "What is Addiction" explains addiction as a chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences. It highlights the dangers of different drug categories, including sedatives, stimulants, and hallucinogens, and their potential he...
